About DTA 2019-04-02T19:35:29+00:00

About DTA

Digital Therapeutics Alliance

Founded in 2017, the Digital Therapeutics Alliance is a non-profit trade association of industry leaders and stakeholders engaged in the evidence-driven advancement of digital therapeutics. DTA maintains an international industry focus and is headquartered in the United States.

MISSION
DTA exists to broaden the understanding, adoption, and integration of clinically-validated digital therapeutics into healthcare through education, advocacy, and research.

VISION
Alliance members work to enable expanded access to high quality, evidence-based digital therapeutics for patients, healthcare providers, and payers in order to improve clinical and health economic outcomes.

Digital Therapeutics: Core Principles 

Digital therapeutics are designed to integrate into patient lifestyles and provider workflows to deliver a fully integrated healthcare experience with improved outcomes. Given the diversity of interventions being delivered by digital therapeutics and the types of disease states addressed, it is important for all products to adhere to industry-adopted core principles and best practices.

Core principles all digital therapeutics must adhere to:

  • Prevent, manage, or treat a medical disorder or disease
  • Produce a medical intervention that is driven by software, and delivered via software or complementary hardware, medical device, service, or medication
  • Incorporate design, manufacture, and quality best practices
  • Engage end users in product development and usability processes
  • Incorporate patient privacy and security protections
  • Apply product deployment, management, and maintenance best practices
  • Publish trial results inclusive of clinically-meaningful outcomes in peer-reviewed journals
  • Be reviewed and cleared or approved by regulatory bodies as required to support product claims of risk, efficacy, and intended use
  • Make claims appropriate to clinical validation and regulatory status
  • Collect, analyze, and apply real world evidence and product performance data

Strategic Advisors

Andrew Matzkin
Health Advances LLC

Bray Patrick-Lake
Duke University

James Spicka
Evolent Health

Jessica Shull
Hospital Bellvitge

Jim McGough
EdgeOne Medical

Kavita Patel
Johns Hopkins Medicine and Brookings Institution

Marc Sluijs
DigitalHealth.Network

Mark Bini
Express Scripts

Pavan Choksi
Arkitekt Ventures

Roberto Ascione
Healthware International

Board of Directors

Alex Waldron
Chief Commercial Officer
Pear Therapeutics

Anand Iyer
Chief Strategy Officer
WellDoc

David Van Sickle
Chief Executive Officer
Propeller Health

Eddie Martucci
Chief Executive Officer
Akili Interactive

Joris van Dam
Head of Digital Therapeutics
Novartis

Peter Hames
Co-Founder and CEO
Big Health

Pierre Leurent
Chief Executive Officer
Voluntis

Megan Coder
Executive Director
Digital Therapeutics Alliance

Senior Staff

Megan Coder

Executive Director, Digital Therapeutics Alliance

Join the DTA Community

ENGAGE & ADVANCE PATIENT OUTCOMES

Connect Now